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Objective. To evaluate the clinical outcome of ﬂexible ureterorenoscopy (F-URS) with holmium laser in managing renal stone
greater than 2cm. Patients and Methods. Records of 120 patients (123 renal units) with renal stone greater than 2cm who
underwent F-URS with holmium laser iwere evaluated. The mean stone size was 26.3mm. Patient and stone characteristics,
perioperative outcomes and complications were evaluated. The outcome was determined at 4 weeks on plain radiograph (KUB)
and Non-contrast CT scan (NCCT). Follow-up visit was up to 6 months to evaluate the clinical outcome and patients symptoms.
Results. Stone burden was an independent predictor of FURS results. After ﬁrst session of treatment, success rate was obtained
in 72 renal units (58.5%). On the other hand, signiﬁcant residual fragment was encountered in 51 renal units (41.5%). This was
improved with “staged-therapy” to 87% and 96.7% after second and third session of treatment, respectively. Complications were
recorded. They were managed in proper manner accordingly. Conclusion. This is an attractive, safe and eﬀective technique. It is an
ideal option for low volume complex stone with average burdens of 2 to 3cm. Patient should be informed and consented about
staged-therapy.
1.Introduction
PCNL has been the standard treatment for renal stone
greater than 2cm [1, 2]. Some authors reported that PCNL
stone-free rate is ranging between 77% and 94% [3, 4].
Extracorporealshockwavelithotripsy (ESWL)forlarge renal
stonerendersStonefree(SF)in51.6%to57%[5].Combined
ESWL with “RIRS” associated holmium laser were described
in comparable results to PCNL [6]. Since Dretler in 1994 [5]
described “staged therapy” of F-URS in complex renal stone
management, ﬂexible endoscopes underwent great advances
in miniaturization as well as durability improvement [5, 7–
12]. Many authors reported high success rate between 77%
and 92%, minimal morbidity, and short hospital stay of this
technique [13–17]. Mariani used electrohydraulic lithotripsy
(EHL)in combinedwith holmium laser reporting promising
results with SF rate up to 92% after 2 to 4 sessions of
treatment [15].Holmiumlaserﬁberwasusedtoachievehigh
stoneclearanceratebyturningurinarystoneintodust,which
was eliminated with irrigation ﬂuid [9, 11, 18]. Patients had
minimal requirement of pain analgesics and consequently a
short hospital stay [19, 20] compared to those patient who
were underwent PCNL for almost same burdens of renal
stone.
2.Patientsand Methods
We reviewed medical records of 120 patients (123 renal
units) who underwent ﬂexible ureteroscopy (F-URS) with
holmiumlaserfromFebruary2004toApril2010.Renalstone
size (deﬁned as the largest stone maximal diameter) was
ranged from 20 to 58mm (mean size 26.3mm). A total of
192 procedures were performed for 120 patients. All patients
were operated by a single urologist (O.T) using diﬀerent
types of ﬂexible ureteroscopes: DUR-8 Elite, Flex-X2, URF-
P5 or URF-V. Holmium laser ﬁbers (150µm, 200µm, and/or
365µ) were used according to stone location. Treatment
indications were subdivided into certain groups with some2 Advances in Urology
Table 1: Treatment indications associated with treatment success.
Treatment indication No. RU Success no. of RU
ESWL treatment failure 54 51 (98%)
PCNL treatment failure 14 12 (85.7%)
Medical treatment failure 14 11 (78.5%)
Medical comorbidities 16 9 (75%)
Bleeding disorders 3 3 (100%)
Morbid obesity 14 11 (78.5%)
Solitary kidney 9 9 (90%)
Pelvic kidney 2 2 (100%)
RU: Renal Unit.
overlap among the groups, including ESWL failure, PCNL
failure, medical therapy failure, obesity, bleedingdisorders as
well as some renal congenital malformation (Table 1). Fifty-
ﬁve renal units (44.7%) were considered as treatment failure
of ESWL. Patient age, sex, body mass index, stone size, site,
composition, associated lower calyx stone, Double-J stent
preoperatively, congenital anomalies, anticoagulant therapy,
intervention duration, preoperative serum creatinine and
complications were evaluated.
2.1. Endoscopic Technique. Flexible ureterorenoscopy tech-
nique in Tenon University Hospital was performed as
described in the literature [8]. In case of complete stone
laser fragmentation was obtained as shown in (Figure 1)
(multiple calyceal renal stones) or in (Figure 2) (a single
renal pelvis stone), we placed Double-J stent. Zero Tip
basket (Boston Scientiﬁc) 1.9-Fr was used to extract any
visible residual fragments for stone analysis. A ureteral
catheter was placed in some patients after a second-look
endoscopy,and when we are sure about stone free status, this
catheter was removed at Day 1 postoperatively. Patients with
uncompleted stone fragmentation were planned for second-
look endoscopy and laser fragmentation or for basketing of
small fragments within 3 weeks. Second look endoscopies
± multiple stage treatment (starting from 2nd session) were
usually performed in day surgery unit in (88%) of patients.
In certain situations like solitary kidney and patients who
were under anticoagulant therapy, we systemically placed
Double-J stent after stone fragmentation. At the end of
procedure, a Foley catheter for 24hr to ensure the maximum
drainage. Patients were advised to force ﬂuidsto facilitate the
physiological evacuation of small fragments.
Stone-free status was routinely determined by plain
radiograph (KUB)and NCCT at 4 weeks for all patients who
had full stone fragmentation. Patients who underwent staged
therapy were evaluated at 4 weeks from the last procedure.
S u c c e s sr a t ew a sc o n s i d e r e da sS Fo rr e s i d u a lf r a g m e n to f
2mm or less. All patients were followed up to 6 months,
with serial plain radiograph or renal ultrasound (Renal
ultrasoundat3and6months).Renalfunctionwascompared
preoperatively and postoperatively using t-test. A metabolic
evaluation was performed on patients after stone clearance.
All statistical analysis was performed (SPSS, version 16.0).
Table 2: Patients’ demographics data and association to treatment
success.
Variable Results P Test
Age (Mean ± SD) years 48.0 ± 15.3 .63 Mann-Whitney
Gender .71 Fisher’s exact
Female 64 (52.0%)
Male 59 (48.0%)
BMI (Mean ± SD) 25.4 ± 6.1 .29 Mann-Whitney
Malformation(RU) .46 Chi-square
Horseshoe kidney 5 (4.3%)
Solitary kidney 9 (7.3%)
Pelvic kidney 2 (1.7%)
Caliceal diverticula 2 (1.7%)
Malrotated kidney 1 (0.9%)
Repaired UPJ obstruction 4 (3.4%)
None 100 (8.3%)
Anticoagulant therapy .91 Fisher’s exact
Yes 3 (2.4%)
No 120 (97.6%)
RU: renal unit, SD: standard deviation.
3.Results
There were 59 male (48%) and 64 female (52.0%). Mean ±
SD patient age was 48 ± 15.3 years (median 45, range 19 to
80).MedianBMIwas25kg/m2 (range18.2to48.7).(Table2)
shows patients demographic data. SF status was found in
58.5%, 87%, and 96.7% after ﬁrst, second, and third sessions
of treatment respectively. SF status in renal units with stone
burden 2 to 3cm was reported in (65.4%), (90.4%), and
(98%) after ﬁrst, second and third sessions respectively. We
performed 192 procedures with mean of 1.6 procedure per
patient, including second-look endoscopies. On the other
hand, renal units with stone greater than 3cm rendered SF
in (21%) after ﬁrst session and improved up to (89.5%) by
“staged therapy” (up to 3 sessions).
3.1. Outcome Predictors. On univariate analysis of the entire
patient group: stone size category (P<. 001) and absence
of access sheath (P = .041) were statistically signiﬁcantly
associated with treatment failure. On multivariate analysis,
only stone burden was an independent predictor over the
outcome. Large stone burden was related to “staged therapy”
(P<. 0001). Thus, it was associated with residual frag-
ments, and longer operating time. However, no statistically
signiﬁcant association was seen between stone size category
and complications (P = .8). Renal anatomical abnormalities
(P = .46) are trended towards a nonsigniﬁcant impact over
success rate. We reported a horseshoe kidney in 5 renal units
(4.3%), a solitary kidney in 9 (7.3%), a caliceal diverticulum
in 2 (1.7%) and a pelvic kidney in 2 (1.7%). Lower calyx
stone was documented in 71 renal units with no signiﬁcant
impact over results (P = .16). There were three patients
on anticoagulant therapy; two patients were rendered stone
free after ﬁrst session. Stone analysis was done in all patients
(Table 3). In this study, mean operative time was 89 minutesAdvances in Urology 3
Figure 1: Complete laser fragmentation of multiple renal stones in a single session of F-URS.
Figure 2: Complete laser fragmentationof large renal pelvis in a single sessionof F-URS.
(range60to 140).Operative time wassigniﬁcantly correlated
to the stone size (P<. 0001).Nevertheless,it was not aﬀected
b ys t o n es i t e( P = .35). Hospital stay was ranged between 1
to 3 days (mean = 34.6 hours).
Preoperative and postoperative renal function (creati-
nine) was evaluatedbyt-test (P = .16),concludingthat there
was no immediate change in renal function postoperatively
which should be also evaluated over the long term.
3.2. Complications. We reported mild-to-moderate Double
J stent discomfort in 47% of patients. Those patients were
evaluated during hospitalization or at outpatient clinic post-
operatively. Complications intra-operatively or postoper-
atively were reported in Table 4. Three patients had a
temporary hematuria postoperatively, which was resolved
within 48 hours and none of them was under anticoagu-
lant therapy. Three patients were admitted approximately
one week postoperatively (1 pyelonephritis, 1 prostatitis
and 1 Obstructive pyelonephritis). All were managed with
appropriate antibiotics; for the last patient renal drainage
was carried out. We have encountered two patients with
steinstrasse phenomenonthattreatedendoscopicallywith no
major sequences. Subcapsular hematoma was documented
in 2 patients who had no preoperative morbidities. Large4 Advances in Urology
Table 3: Stone Demographics characteristics, preoperative and
intraoperative data.
Variable Results P value Test
Size (SD) mm 26.3 ± 7.3 .001 Fisher’s exact
20–30 104 (84.6%)
>30 19 (15.4%)
Associated lower
calyx stone .16 Fisher’s exact
Yes 71 (57.7%)
No 52 (42.3%)
Site (RU) .85 Chi-square
Pelvic 22 (17.9%)
Lower calyx 13 (10.6%)
Middle calyx 1 (0.8%)
Upper calyx 2 (1.6%)
Mixed pelvic and
calyces 67 (54.5%)
Mixed calyces 18 (14.6%)
Stone Nature .22 Chi-square
Ca oxalate 71 (57.7%)
Mixed 9 (7.3%)
Uric acid 7 (5.7%)
Brushite 11 (9.0%)
Struvite 6 (4.9%)
Cystine 19 (15.4%)
Stone number .81 Fisher’s exact
Isolated 53 (43.1%)
Multiple 70 (56.9%)
Preoperative DJ stent .44 Fisher’s exact
Yes 81 (65.9%)
No 42 (34.1%)
Operative time
(minute) 89 ± 24 .34 Mann-
Whitney
Use of ureteral access
sheath 117 (95.1%) .041 Fisher’s exact
stone burden was not associated with a greater transfusion
requirement neither complication rate.
4.Discussion
PCNL is the standard treatment for large and/or complex
stone. However, there are many reports trying to deﬁne
the minimal stone size for PCNL. Since 1980s, retrograde
endoscopic management of upper urinary tract stone had
undergone and still undergoing an enormous technical
development. In the early 1990s, this technique associated
with holmium laser was considered as one of renal stone
managment modalities [9, 10]. It is indicated in certain
conditions like ESWL treatment failure, medical treatment
failureorPCNLfailure,obesity,anatomicalanomaliesaswell
as bleeding diathesis. ESWL does not carry high success for
renal stone greater than 2cm; moreover, stone-free rate of
Table 4: Intraoperative and postoperative complications.
Intraoperative
Bleeding 1
Perforation (renal pelvis) 1
Fornix rupture 3
Postoperative
Prostatitis 1
Non obstructive pyelonephritis 1
Obstructive pyelonephritis 1
Steinstrasse 2
Subcapsular hematoma 2
Temporary hematuria 3
ESWL for lower pole stone is limited. Several studies were
published regarding URS with holmium laser in treating
upper urinary tract stone greater than 2cm or even complex
renal stone with comparable results to PCNL [12–17]. Use
of actively deﬂectable ureteroscopes improved exploration
of the renal collecting system. Holmium laser lithotripsy
introduction into endourological ﬁeld and stone treatment
allowed us to turn urinary stone to small fragments, which
are evacuated with the irrigation ﬂuid intraoperatively or in
a physiological manner postoperatively [9, 11, 18]. Compli-
cation rate of F-URS is not well reported, nevertheless, most
of recent studies did not report any major complications
[12,14–17]likeperforation orureteralavulsion compared to
semirigid URS [19–21]. PCNL complication rate is reported
to be as high as 83% [4, 22], while small size URS had
rate of 1.5% [20]. In our series, some complications were
recognized. Febrile urinary tract infections were managed
appropriately.Postoperatively,theonlystriking eventwasthe
subcapsularhematoma.Thiswasnotrelatedtoanticoagulant
therapy neither to operating time. Over a period of 6-month
followup, no ureteral stricture was reported.
Large stone burden was signiﬁcantly associated with
greater likelihood of repeated sessions, higher probability of
residual fragments, and longer operating time. Grasso and
associates 1998[14],obtained91%stone free withprocedure
mean of 1.5 for ureteral and renal stones. In regard to
operative time, Breda and coworkers [17], reported a mean
operative time of 83 minutes (range 45 to 140 minutes) for
mean stone burden of 22mm. Mariani [23]h a dam e a n
operative time of 64 minutes (30 to 240 minutes) for mean
stone burden of 33mm using EHL. In this work, the main
operative time is 89 minutes (range 60 to 140 minutes). We
referred this to two possible factors; ﬁrst, the presence of
lower pole stone in 71 renal units (57.7%) since lower calyx
stone related was related long operative time. The second
factor was stone nature, since we noticed that those patients
with cystine renal stone (15.4%) had longer operative time
range from (90 to 124 minutes) with mean of 98 minutes
comparing to the other types of stone. The use of F-URS
with holmium laser for obese patient is very useful, as
many reports described PCNL technically demanding withAdvances in Urology 5
Table 5: Literature review for ﬂexible ureteroscopic and holmium
laser management for stone larger than 2cm.
Study No. Pts Mean stone
size mm
Average number
of procedure SF%
Riley et al. [27] 22 24 1.82 90.9
Breda et al. [17] 15 22 2.3 93.3
Grasso et al.
[14]
51 26.7 (renal) 1.3 91
El-Anany et al.
[16]
30 NM 1 77
Our series 120 26 1.6 95.9
NM: not mentioned, SF: stone free.
high risk of complications [19]. We reported 14 renal units
(11.4%) in obese patients (BMI > 30), and 78.5% were
rendered stone free without any major complications or
blood transfusion.
Preoperative stenting was not import to address in
this study. Some reports suggested that preoperative stents
passively dilated the ureter, allowing for high success rate,
but there was no report on statistical signiﬁcant [24].
In this work, the eﬀect of preoperative stenting was not
signiﬁcant in all groups (P = .44). For the group 1, 2cm
to 3cm was also not signiﬁcant (P = .13). The use of
access sheath decrease operative time and costs and allow
direct insertion of endoscope to the renal cavities with a
simple entry and then to visualize renal cavities [25]. It
has been shown to extend the durability of ureteroscopes.
Nevertheless, complications might occur related to this
instrumentlikeureteralperforationorevenstrictureoverthe
long term. Delvecchio and coworkers reported the safety of
this instrument identifying only one postoperative ureteral
stricture from followup of (71) F-URS procedures with an
incidence of 1.4% [26].
The stone size was not homogenously distributed(84.6%
of renal units stones are between 2cm and 3cm); this
was probably due to inclusion criteria (failure of ESWL
treatment). We considered this as one of the limits of this
study since F-URS is performed as an ancillary procedure
after ESWL failure. Due to lack of comparative data, we
presented this technique. Up to our knowledge, this is the
largestseriesofpatientswith stoneburdensgreaterthan2cm
managedbyF-URSwithholmiumlaser(Table5).Ourresults
are comparable, if not superior to, previously published
reports of F-URS laser lithotripsy for smaller mean stone
burdens and also low rates of recurrence, although most
series have limited followup like this study. From this study,
we emphasize that F-URS with holmium laser lithotripsy is
safe and eﬀective for management of 2 to 3cm renal stones.
Nevertheless, Retreatment rate for this group (2 to 3cm)
was 34.6%, which is less than other reports. Success rate
was strongly associated with stone size; therefore, “staged
therapy” should be carefully discussed with the patient who
has a large-volume renal stone. Moreover, success rate for
renal stone (greater than 3cm) reached almost 90% after 3
sessions.
5.Conclusions
As PCNL remains the golden standard for large renal
stone, F-URS with holmium laser is an attractive safe and
eﬀective technique with low morbidity and high success
rate. Therefore, it could be proposed as a real alternative
therapy to PCNL for certain indications (group of high risk).
However, this technique is an ideal option for low-volume
complex stone with average burdens of 2 to 3cm. Patient
should be informed and consented about staged-therapy.
Further comparative studies should be conducted between
groups of patients with certain indications to lineate the best
treatment option.
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